Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$479M |
| 2 |
Meta Platforms (Facebook)
META
|
+$465M |
| 3 |
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
|
+$445M |
| 4 |
Kenvue
KVUE
|
+$434M |
| 5 |
Micron Technology
MU
|
+$431M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$3.24B |
| 2 |
Apple
AAPL
|
+$1.9B |
| 3 |
Microsoft
MSFT
|
+$1.56B |
| 4 |
PepsiCo
PEP
|
+$1.34B |
| 5 |
JPMorgan Chase
JPM
|
+$1.34B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.7% |
| 2 | Financials | 7.47% |
| 3 | Consumer Discretionary | 6.7% |
| 4 | Communication Services | 6.02% |
| 5 | Healthcare | 4.93% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
426
CALL
Akamai
AKAM
$17B
| $120M | 0.03% |
1,373,600
-704,300
| -34% | -$57.9M |
|
|
FITB
427
Fifth Third Bancorp
FITB
$51.7B
| $120M | 0.03% |
2,557,899
-1,389,347
| -35% | -$61.2M |
|
428
PUT
Palo Alto Networks
PANW
$309B
| $120M | 0.03% |
649,400
+187,100
| +40% | +$37.7M |
|
429
Targa Resources
TRGP
$56.1B
| $120M | 0.03% |
647,921
-98,491
| -13% | -$16.6M |
|
|
430
CALL
JPMorgan Chase
JPM
$951B
| $119M | 0.03% |
370,700
-108,400
| -23% | -$33.6M |
|
431
Trade Desk
TTD
$6.09B
| $119M | 0.03% |
3,128,361
+79,923
| +3% | +$3.54M |
|
432
SoFi Technologies
SOFI
$23.4B
| $117M | 0.03% |
4,480,969
+2,869,042
| +178% | +$79.9M |
|
433
DTE Energy
DTE
$28.7B
| $117M | 0.03% |
907,754
-12,232
| -1% | -$1.66M |
|
434
PUT
iShares Silver Trust
SLV
$31.4B
| $117M | 0.03% |
1,815,000
+1,400,000
| +337% | +$70.1M |
|
435
KeyCorp
KEY
$24.3B
| $117M | 0.03% |
5,660,292
+422,506
| +8% | +$7.87M |
|
436
Snowflake
SNOW
$116B
| $117M | 0.03% |
531,927
-145,072
| -21% | -$35.4M |
|
437
lululemon athletica
LULU
$14.4B
| $116M | 0.03% |
560,539
-39,773
| -7% | -$7.21M |
|
438
Raymond James Financial
RJF
$34.3B
| $116M | 0.03% |
724,251
+126,572
| +21% | +$20.4M |
|
439
PUT
McDonald's
MCD
$194B
| $116M | 0.03% |
378,500
-175,000
| -32% | -$53.6M |
|
440
Public Service Enterprise Group
PEG
$37.1B
| $116M | 0.03% |
1,439,753
+523,306
| +57% | +$42.7M |
|
441
Hartford Financial Services
HIG
$39.2B
| $116M | 0.03% |
838,719
-383,583
| -31% | -$50.6M |
|
442
PUT
Analog Devices
ADI
$189B
| $115M | 0.03% |
424,300
+27,100
| +7% | +$6.81M |
|
443
Nucor
NUE
$62.7B
| $115M | 0.03% |
703,530
-61,234
| -8% | -$9.2M |
|
444
Sysco
SYY
$40.3B
| $115M | 0.03% |
1,555,548
-298,714
| -16% | -$22.7M |
|
445
Albemarle
ALB
$15.5B
| $114M | 0.03% |
804,936
-435,017
| -35% | -$49.4M |
|
446
Lumentum
LITE
$65.7B
| $113M | 0.03% |
307,836
+58,037
| +23% | +$14.9M |
|
447
iShares Biotechnology ETF
IBB
$9.78B
| $113M | 0.03% |
671,941
+255,750
| +61% | +$41.5M |
|
448
Ameren
AEE
$29.6B
| $113M | 0.03% |
1,134,784
-149,798
| -12% | -$15.4M |
|
449
CALL
Palantir
PLTR
$429B
| $113M | 0.03% |
634,100
-13,000
| -2% | -$2.35M |
|
450
CALL
Norwegian Cruise Line
NCLH
$8.6B
| $112M | 0.03% |
5,031,900
+4,431,900
| +739% | +$93.6M |
|
Similar funds
Barclays's Q4 2025 Portfolio in Review
As of Q4 2025, Barclays held 5,847 positions worth $417B, down 9.7% from $461B the previous quarter. Its ten largest holdings account for 35% of the portfolio.
Barclays withdrew a net $49.1B in Q4 2025, closing 641 positions and reducing 1,715 holdings. Its most notable exit was Verona Pharma, an estimated $149M position sold in full.
By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 20% a quarter earlier, followed by Financials and Consumer Discretionary.
Against the trend, Barclays opened a new position in The Magnum Ice Cream Company N.V. worth $156M.
- Barclays's largest Q4 2025 buy was The Magnum Ice Cream Company N.V.: 9,862,859 shares worth $156M.
- Barclays added most to Gilead Sciences in Q4 2025, an estimated $479M increase.
- Barclays's biggest Q4 2025 reduction was NVIDIA, cutting an estimated $3.24B.
- Barclays fully exited Verona Pharma in Q4 2025, selling an estimated $149M.
- Barclays's ten largest holdings make up 35% of its $417B portfolio in Q4 2025.
- Barclays opened 403 new positions and closed 641 in Q4 2025.
- Barclays's portfolio value fell 9.7% quarter-over-quarter to $417B.
Based on Barclays's 13F filing for Q4 2025, filed 13 Feb 2026.